Drug recall
Semprex-D Capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride), 100 Capsule bottles, Rx only…
FDA recall event 55174 · Class III · Ucb Manufacturing, Inc.
Key facts
| Event ID | 55174 |
|---|---|
| Recall numbers | D-549-2010 |
| Recalling firm | Ucb Manufacturing, Inc. |
| Product type | Drugs |
| Products | Semprex-D Capsules (8 mg acrivastine/60 mg pseudoephedrine hydrochloride), 100 Capsule bottles, Rx only --- Marketed by UCB, Inc., Smyrna, GA 30080, Manufactured by: DSM Pharmaceuticals, Inc… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Impurities/Degradation products. |
| Initiation date | Mar 25, 2010 |
| Termination date | Sep 17, 2010 |
| City | Rochester |
| State | NY |
| Country | United States |
| FEI number | 1314625 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports